Laboratory Corporation of America Holdings (NYSE:LH) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Chas Cook - VP, IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants Jack Meehan - Nephron Research Erin Wright - Morgan Stanley Patrick Donnelly - Citigroup Eric Coldwell - Robert W. Baird & Co. A.J. Rice - Crédit Suisse Rachel Vatnsdal - JPMorgan Chase & Co. John Kim - Bank of America Merrill Lynch Kevin Caliendo - UBS Oper ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Securities registered pursuant to Section 12(b) of the Exchange Act. | Title of Each Class | Trading Symbol | Name of exchange on which registered | | --- | --- | --- | | Common Stock, $0.10 par value ...

Laboratory Corporation of America Holdings (NYSE:LH) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Chas Cook - VP, IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants Rivka Goldwasser - Morgan Stanley A.J. Rice - Crédit Suisse Taji Phillips - Jefferies Jack Meehan - Nephron Research Eric Coldwell - Robert W. Baird & Co. Derik De Bruin - Bank of America Merrill Lynch Matthew Larew - William Blair & Company Rachel Vatnsdal - J ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-37573 ...

First Quarter 2022 Supplemental Financial Information April 28, 2022 labcorp Cautionary Statement Regarding Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, statements with respect to (i) the estimated 2022 guidance and related assumptions, (ii) the impact of various factors on operating and financial results, including the projected impact of the COVID-19 pandemic on the company's businesses, operating results, cash flows and/or financial cond ...

Laboratory Corporation of America Holdings (NYSE:LH) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Chas Cook - Vice President, Investor Relations Adam Schechter - Chairman and Chief Executive Officer Glenn Eisenberg - Executive Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Ricky Goldwasser - Morgan Stanley Eric Coldwell - Baird Operator Good day, and thank you for standing by. Welcome to the Labcorp's First Quarter 20 ...

Index UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [☒] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or [☐] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ to ______ Commission file number - 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) Delaware 13-3757 ...

Laboratory Corporation of America Holdings (NYSE:LH) Q4 2021 Earnings Conference Call February 10, 2022 9:00 AM ET Company Participants Chas Cook - VP, IR Adam Schechter - CEO and Chairman Glenn Eisenberg - EVP and CFO Conference Call Participants Jack Meehan - Nephron Research A.J. Rice - Credit Suisse Ricky Goldwasser - Morgan Stanley Patrick Donnelly - Citi Eric Coldwell - Baird Brian Tanquilut - Jefferies Kevin Caliendo - UBS Pito Chickering - Deutsche Bank Derik De Bruin - Bank of America Madeline Moll ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-3 ...

Third Quarter 2021 Supplemental Financial Information October 28, 2021 labcorp CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Cautionary Statement Regarding Forward-Looking Statements This presentation of Laboratory Corporation of America Holdings contains forward-looking statements, statements with respect to (i) the estimated 2021 guidance and the related assumptions, (ii) the impact of various factors on operating and financial results, including the projected impact of the COVID-19 pandemic o ...